The repurposing of metformin or TZDs for neuroprotection in AD and PD remains a promising, but not yet conclusively proven, strategy
Patients in the high-risk group exhibited down-regulated immune-effector pathways, elevated expression of the checkpoint molecules PD-L1 and LAG-3, and a trend toward an immune-evasive phenotype, suggesting potential resistance to immunotherapy
These compounds work together to stimulate the liver and help it process fats more effectively, leading to weight loss
Your journey to radiant, youthful, glowing skin starts now
GLP-1 drugs are primarily used for: Managing blood sugar levels in type 2 diabetes Promoting weight loss in individuals with obesity Reducing cardiovascular risk in some patients with type 2 diabetes These medications have shown significant benefits in glycemic control and weight reduction, making them increasingly popular among healthcare providers and patients alike